chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 70.0
Sex: M
Vaccine: COVID19
Symptoms: Hypoaesthesia oral, Myalgia, Pain in extremity, Paraesthesia, SARS-CoV-2 test
Clinical narrative: numbness in mouth; tingling in fingers/toes; pain in feet; loss of taste; muscle pain; joint pain; fatigue; headache; chills; This spontaneous case was reported by a consumer and describes the occurrence of HYPOAESTHESIA ORAL (numbness in mouth), PARAESTHESIA (tingling in fingers/toes), PAIN IN EXTREMITY (pain in feet), AGEUSIA (loss of taste) and MYALGIA (muscle pain) in a 70-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19 on 21-Dec-2020. Concurrent medical conditions included Food allergy, Drug allergy (Hydrocodone allergy, Inderal allergy), High cholesterol, Diabetes, Blood pressure high, Atrial fibrillation and Prostate examination abnormal (prostate issues unspecified). Concomitant products included METFORMIN, PRAVASTATIN, LISINOPRIL, SOTALOL, RIVAROXABAN (XARELTO) and FINASTERIDE for an unknown indication.    On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-Feb-2021, the patient experienced MYALGIA (muscle pain), ARTHRALGIA (joint pain), FATIGUE (fatigue), HEADACHE (headache) and CHILLS (chills). On 12-Feb-2021, the patient experienced HYPOAESTHESIA ORAL (numbness in mouth), PARAESTHESIA (tingling in fingers/toes), PAIN IN EXTREMITY (pain in feet) and AGEUSIA (loss of taste). At the time of the report, HYPOAESTHESIA ORAL (numbness in mouth), PARAESTHESIA (tingling in fingers/toes), PAIN IN EXTREMITY (pain in feet), AGEUSIA (loss of taste), MYALGIA (muscle pain), ARTHRALGIA (joint pain), FATIGUE (fatigue), HEADACHE (headache) and CHILLS (chills) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 21-Dec-2020, SARS-CoV-2 test: positive (Positive) positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Treatment medication not reported.
Sex: F
Vaccine: COVID19
Symptoms: Adverse drug reaction
Clinical narrative: side effects; This spontaneous case was reported by a consumer and describes the occurrence of ADVERSE DRUG REACTION (side effects) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 01-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ADVERSE DRUG REACTION (side effects). At the time of the report, ADVERSE DRUG REACTION (side effects) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medications details were not reported by the reporter. Treatment details was not reported by the reporter.   Reporter did not allow further contact
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Headache, Nasal congestion, Oropharyngeal pain, Pyrexia
Clinical narrative: This spontaneous case was reported by a nurse (subsequently medically confirmed) and describes the occurrence of OROPHARYNGEAL PAIN (Sore throat), NASAL CONGESTION (Congestion), RHINORRHOEA (Runny nose), PYREXIA (Fever 99.4F) and HEADACHE (Headache) in a 54-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 06-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 31-Jan-2021, the patient experienced NASAL CONGESTION (Congestion) and RHINORRHOEA (Runny nose). On 02-Feb-2021, the patient experienced OROPHARYNGEAL PAIN (Sore throat) and HEADACHE (Headache). On an unknown date, the patient experienced PYREXIA (Fever 99.4F). At the time of the report, OROPHARYNGEAL PAIN (Sore throat), NASAL CONGESTION (Congestion), RHINORRHOEA (Runny nose), PYREXIA (Fever 99.4F) and HEADACHE (Headache) outcome was unknown. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 02-Feb-2021, COVID-19: positive Positive. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. No concomitant medication was taken. No treatment medication was taken.
Sex: F
Vaccine: COVID19
Symptoms: Rhinorrhoea
Clinical narrative: This spontaneous case was reported by a nurse (subsequently medically confirmed) and describes the occurrence of OROPHARYNGEAL PAIN (Sore throat), NASAL CONGESTION (Congestion), RHINORRHOEA (Runny nose), PYREXIA (Fever 99.4F) and HEADACHE (Headache) in a 54-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 06-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 31-Jan-2021, the patient experienced NASAL CONGESTION (Congestion) and RHINORRHOEA (Runny nose). On 02-Feb-2021, the patient experienced OROPHARYNGEAL PAIN (Sore throat) and HEADACHE (Headache). On an unknown date, the patient experienced PYREXIA (Fever 99.4F). At the time of the report, OROPHARYNGEAL PAIN (Sore throat), NASAL CONGESTION (Congestion), RHINORRHOEA (Runny nose), PYREXIA (Fever 99.4F) and HEADACHE (Headache) outcome was unknown. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 02-Feb-2021, COVID-19: positive Positive. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. No concomitant medication was taken. No treatment medication was taken.
Sex: U
Vaccine: COVID19
Symptoms: Herpes zoster
Clinical narrative: shingles; This spontaneous case was reported by a consumer and describes the occurrence of HERPES ZOSTER (shingles) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced HERPES ZOSTER (shingles). At the time of the report, HERPES ZOSTER (shingles) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       No concomitant medication details was reported. No treatment medication details was reported.   Most recent FOLLOW-UP information incorporated above includes: On 03-May-2021: NNI
Age: 92.0
Sex: U
Vaccine: COVID19
Symptoms: Dyspnoea, Pain
Clinical narrative: can't breathe well; Aches; This spontaneous case was reported by a consumer and describes the occurrence of DYSPNOEA (can't breathe well) and PAIN (Aches) in a 92-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 022M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 23-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced DYSPNOEA (can't breathe well) and PAIN (Aches). The patient was treated with PARACETAMOL (TYLENOL) at a dose of UNK dosage form. At the time of the report, DYSPNOEA (can't breathe well) and PAIN (Aches) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication details was reported.
Age: 71.0
Sex: M
Vaccine: COVID19
Symptoms: Rash morbilliform
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of RASH MORBILLIFORM (dark, rash, which looked like measles on both inner thighs and both lower legs) in a 71-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 0028L20a) for COVID-19 vaccination.     Concomitant products included ATORVASTATIN, METHYLPHENIDATE HYDROCHLORIDE (RITALIN) and CELECOXIB (CELEBREX) for an unknown indication.    On 31-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Feb-2021, the patient experienced RASH MORBILLIFORM (dark, rash, which looked like measles on both inner thighs and both lower legs). At the time of the report, RASH MORBILLIFORM (dark, rash, which looked like measles on both inner thighs and both lower legs) was resolving.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment information was not provided.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
Sex: U
Vaccine: COVID19
Symptoms: Accidental underdose
Clinical narrative: A spontaneous report was received from a nurse concerning ten patients, who received lower dose for the second dose (0.3 mL dose instead of a 0.5 mL dose) of Moderna's COVID-19 vaccine (mRNA-1273).  The medical history of the patients was not provided. No relevant concomitant medication was reported.  On an unknown date, the patients received their second of the two planned doses of mRNA-1273 (Batch Number: unknown) intramuscularly for prophylaxis of COVID-19 infection.  On the vaccination day, approximately ten patients received a lower dose for the second dose. The patients were administered with 0.3 mL dose instead of a 0.5 mL dose accidently. No treatment information was provided.  Action taken with mRNA-1273 in response to the event was not reported.    The outcome of the event, lower dose for the second dose (0.3 mL dose instead of a 0.5 mL dose), was resolved.; Reporter's Comments: This report refers to a case 10 patients of accidental underdose for mRNA-1273 (lot # 024M20A) with no associated AEs reported.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Feeling abnormal, Flushing, Headache, Hot flush
Clinical narrative: headache; weird flushing; hot flashes; flushing face; passed menopause, but this is what it felt like; This spontaneous case was reported by a consumer and describes the occurrence of FLUSHING (weird flushing), HOT FLUSH (hot flashes), FLUSHING (flushing face), FEELING ABNORMAL (passed menopause, but this is what it felt like) and HEADACHE (headache) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 02UM20A) for COVID-19 vaccination.     No Medical History information was reported.    On 27-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Mar-2021, the patient experienced FLUSHING (weird flushing), HOT FLUSH (hot flashes), FLUSHING (flushing face) and FEELING ABNORMAL (passed menopause, but this is what it felt like). On 02-Mar-2021, the patient experienced HEADACHE (headache). The patient was treated with IBUPROFEN (ADVIL [IBUPROFEN]) at a dose of UNK dosage form. At the time of the report, FLUSHING (weird flushing), HOT FLUSH (hot flashes), FLUSHING (flushing face), FEELING ABNORMAL (passed menopause, but this is what it felt like) and HEADACHE (headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medication details was reported.
Age: 88.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue, Headache, Limb discomfort, Myalgia
Clinical narrative: freeze arm; fell tired and icky; Headache; Arm sore; Chills; This spontaneous case was reported by a consumer and describes the occurrence of LIMB DISCOMFORT (freeze arm), FATIGUE (fell tired and icky), HEADACHE (Headache), MYALGIA (Arm sore) and CHILLS (Chills) in an 88-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 014M20A) for COVID-19 vaccination.     The patient's past medical history included COVID-19 in November 2020. Concomitant products included AMLODIPINE BESILATE (NORVASC) for Blood pressure high, ESCITALOPRAM (DEPRALIN [ESCITALOPRAM]) for Stomach pain, VITAMINS NOS for an unknown indication.    On 25-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced LIMB DISCOMFORT (freeze arm), FATIGUE (fell tired and icky), HEADACHE (Headache), MYALGIA (Arm sore) and CHILLS (Chills). At the time of the report, LIMB DISCOMFORT (freeze arm), FATIGUE (fell tired and icky), HEADACHE (Headache), MYALGIA (Arm sore) and CHILLS (Chills) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Most recent FOLLOW-UP information incorporated above includes: On 21-Jul-2021: Follow up information received on 21-Jul-2021 and included non-significant information
Age: 87.0
Sex: F
Vaccine: COVID19
Symptoms: Confusional state
Clinical narrative: Temporary Confusion; This spontaneous case was reported by a consumer and describes the occurrence of CONFUSIONAL STATE (Temporary Confusion) in an 87-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 02-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Mar-2021, the patient experienced CONFUSIONAL STATE (Temporary Confusion). At the time of the report, CONFUSIONAL STATE (Temporary Confusion) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication details was reported. No treatment medication details was reported.
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site erythema, Injection site induration, Injection site warmth, Vaccination site erythema, Vaccination site mass
Clinical narrative: lump at injection site; warm; hard; arm was red again; red spot size of quarter; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE ERYTHEMA (red spot size of quarter), VACCINATION SITE ERYTHEMA (arm was red again), VACCINATION SITE MASS (lump at injection site), INJECTION SITE WARMTH (warm) and INJECTION SITE INDURATION (hard) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 016M20A) for COVID-19 vaccination.     The patient's past medical history included Allergy.    On 08-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 09-Feb-2021, the patient experienced INJECTION SITE ERYTHEMA (red spot size of quarter). On 14-Feb-2021, the patient experienced VACCINATION SITE ERYTHEMA (arm was red again). On 15-Feb-2021, the patient experienced VACCINATION SITE MASS (lump at injection site), INJECTION SITE WARMTH (warm) and INJECTION SITE INDURATION (hard). At the time of the report, INJECTION SITE ERYTHEMA (red spot size of quarter), VACCINATION SITE ERYTHEMA (arm was red again), VACCINATION SITE MASS (lump at injection site) and INJECTION SITE WARMTH (warm) had not resolved and INJECTION SITE INDURATION (hard) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication details was reported. No treatment medication details was reported.
Age: 75.0
Sex: M
Vaccine: COVID19
Symptoms: Urticaria
Clinical narrative: hives on tummy and under arm; This spontaneous case was reported by a consumer and describes the occurrence of URTICARIA (hives on tummy and under arm) in a 75-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 19-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Mar-2021, the patient experienced URTICARIA (hives on tummy and under arm). The patient was treated with CORTISONE ongoing since an unknown date for Adverse event, at a dose of 1 dosage form; DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) ongoing since an unknown date for Adverse event, at a dose of 1 dosage form and CALAMINE, GLYCEROL, ZINC OXIDE (CALAMINE LOTION) ongoing since an unknown date for Adverse event, at a dose of 1 dosage form. At the time of the report, URTICARIA (hives on tummy and under arm) had resolved.            No concomitant medication was reported.   Most recent FOLLOW-UP information incorporated above includes: On 09-Jul-2021: Significant Follow up, event outcome updated to recovered.
Age: 77.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site swelling
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE SWELLING (Swelling and redness around the injection site on her arm) and VACCINATION SITE ERYTHEMA (Swelling and redness around the injection site on her arm) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001A21A) for COVID-19 vaccination.     Concurrent medical conditions included Cholesterol total abnormal NOS. Concomitant products included LEVOTHYROXINE for an unknown indication.   On 28-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Mar-2021, the patient experienced VACCINATION SITE SWELLING (Swelling and redness around the injection site on her arm) and VACCINATION SITE ERYTHEMA (Swelling and redness around the injection site on her arm). At the time of the report, VACCINATION SITE SWELLING (Swelling and redness around the injection site on her arm) and VACCINATION SITE ERYTHEMA (Swelling and redness around the injection site on her arm) outcome was unknown.            Other concomitant medication included cholesterol medication.  The patient received both scheduled doses of mRNA-1273 prior to the event, therefore action taken with the drug in response to the event is not applicable.
Age: 69.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Lymph node pain, Vaccination site discolouration
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of LYMPH NODE PAIN (lymph nodes feel like bee stings), VACCINATION SITE DISCOLOURATION (injection arm is yellow) and FATIGUE (tired) in a 69-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030M20A) for COVID-19 vaccination. No Medical History information was reported. On 03-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-Feb-2021, the patient experienced VACCINATION SITE DISCOLOURATION (injection arm is yellow). On an unknown date, the patient experienced LYMPH NODE PAIN (lymph nodes feel like bee stings) and FATIGUE (tired). At the time of the report, LYMPH NODE PAIN (lymph nodes feel like bee stings), VACCINATION SITE DISCOLOURATION (injection arm is yellow) and FATIGUE (tired) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. No concomitant medication details was reported. No treatment medication details was reported.
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Vitreous floaters
Clinical narrative: eye floater; This spontaneous case was reported by a consumer and describes the occurrence of VITREOUS FLOATERS (eye floater) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031L20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event. Concomitant products included CALCIUM, MAGNESIUM, VITAMIN E NOS (VITAMIN E + MAGNESIUM), CALCIUM CARBONATE, COLECALCIFEROL (VITAMIN D 2000), MULTIVITAMIN & MINERAL, ASCORBIC ACID, VACCINIUM MACROCARPON (CRANBERRY + C) and NAPROXEN for an unknown indication.    On 11-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 11-Feb-2021, the patient experienced VITREOUS FLOATERS (eye floater). At the time of the report, VITREOUS FLOATERS (eye floater) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No treatment details was included.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Feeling abnormal, Headache, Muscle strain, Neck pain
Clinical narrative: Limp feeling; Had a strain on her neck, on left side, which is the same side the injection was given.; Soreness on the left side from his neck to the base of his skull within 4 hours of the vaccination; Extreme fatigue; Headache; Debilitating frontal headache; This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (Limp feeling), MUSCLE STRAIN (Had a strain on her neck, on left side, which is the same side the injection was given.), FATIGUE (Extreme fatigue), NECK PAIN (Soreness on the left side from his neck to the base of his skull within 4 hours of the vaccination) and HEADACHE (Headache) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 043LZ0A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19 in October 2020.    On 13-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced FEELING ABNORMAL (Limp feeling), MUSCLE STRAIN (Had a strain on her neck, on left side, which is the same side the injection was given.), FATIGUE (Extreme fatigue), NECK PAIN (Soreness on the left side from his neck to the base of his skull within 4 hours of the vaccination), HEADACHE (Headache) and HEADACHE (Debilitating frontal headache). At the time of the report, FEELING ABNORMAL (Limp feeling), MUSCLE STRAIN (Had a strain on her neck, on left side, which is the same side the injection was given.), FATIGUE (Extreme fatigue), NECK PAIN (Soreness on the left side from his neck to the base of his skull within 4 hours of the vaccination), HEADACHE (Headache) and HEADACHE (Debilitating frontal headache) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No treatment and concomitant medication information was reported.   This case was linked to MOD-2021-032172 (Patient Link).
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Fatigue
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (tired) and DIZZINESS (lightheaded) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 032L20A and 010A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 27-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 02-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 02-Mar-2021, the patient experienced FATIGUE (tired) and DIZZINESS (lightheaded). At the time of the report, FATIGUE (tired) and DIZZINESS (lightheaded) outcome was unknown.            No concomitant medication details was reported. No treatment medication details was reported. Action taken with mRNA-1273 in response to the events was not applicable.
Age: 67.0
Sex: M
Vaccine: COVID19
Symptoms: Back pain, Pain in extremity
Clinical narrative: nagging upper back pain and lower back pain; nagging upper back pain and lower back pain; Pain in my left side; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Pain in my left side), the first episode of BACK PAIN (nagging upper back pain and lower back pain) and the second episode of BACK PAIN (nagging upper back pain and lower back pain) in a 67-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 022M20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event. Concomitant products included ATENOLOL, RANOLAZINE (RANEXA), LOVASTATIN, AMLODIPINE, ASA, CLOPIDOGREL and GLYCERYL TRINITRATE (NITROGLYCERIN TRANSDERMAL SYSTEM) for an unknown indication.    On 27-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Mar-2021, the patient experienced PAIN IN EXTREMITY (Pain in my left side). On 02-Mar-2021, the patient experienced the first episode of BACK PAIN (nagging upper back pain and lower back pain) and the second episode of BACK PAIN (nagging upper back pain and lower back pain). On 02-Mar-2021, PAIN IN EXTREMITY (Pain in my left side) had resolved. At the time of the report, last episode of BACK PAIN (nagging upper back pain and lower back pain) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No treatment medication details was reported.
Age: 75.0
Sex: M
Vaccine: COVID19
Symptoms: Injection site erythema, Vaccination site warmth
Clinical narrative: arm was red and warm below injection site; arm was red and warm below injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (arm was red and warm below injection site) and INJECTION SITE ERYTHEMA (arm was red and warm below injection site) in a 75-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 031L20A and 030L2A) for COVID-19 vaccination.     Concurrent medical conditions included Hypertension (High blood pressure) since 1978. Concomitant products included FISH OIL for Cholesterol, HYDROCHLOROTHIAZIDE, LOSARTAN POTASSIUM (LOSARTAN/HIDROCLOROTIAZIDA) for Hypertension, ASPIRIN [ACETYLSALICYLIC ACID] and VITAMIN D3 for an unknown indication.   On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 18-Feb-2021, the patient experienced VACCINATION SITE WARMTH (arm was red and warm below injection site) and INJECTION SITE ERYTHEMA (arm was red and warm below injection site). On 22-Feb-2021, VACCINATION SITE WARMTH (arm was red and warm below injection site) and INJECTION SITE ERYTHEMA (arm was red and warm below injection site) had resolved.            No treatment information provided by Reporter.   This case was linked to MOD-2021-094031, MOD-2021-094031 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 27-Apr-2021: Follow-up received. Patient details,Medical history, concomitant medications added
Age: 78.0
Sex: M
Vaccine: COVID19
Symptoms: Dizziness, Pruritus, Rash
Clinical narrative: itching /  Itching on lower legs / Itching on scalp; dizzy/lightheaded; rash on his chest, shoulders, both arms, on calf area and mid-back.; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (dizzy/lightheaded), PRURITUS (itching /  Itching on lower legs / Itching on scalp) and RASH (rash on his chest, shoulders, both arms, on calf area and mid-back.) in a 78-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031M20A) for COVID-19 vaccination.     Concurrent medical conditions included Drug allergy (Ibuprofen allergy, leading to stomach bleeding.) and Pollen allergy (sneezing, runny nose) since May 1956. Concomitant products included ACETAMINOPHEN, SILDENAFIL, METRONIDAZOLE and PROBIOTICS NOS for an unknown indication.    On 10-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Feb-2021, the patient experienced RASH (rash on his chest, shoulders, both arms, on calf area and mid-back.). On 03-Mar-2021, the patient experienced DIZZINESS (dizzy/lightheaded). On an unknown date, the patient experienced PRURITUS (itching /  Itching on lower legs / Itching on scalp). The patient was treated with HYDROCORTISONE at a dose of UNK dosage form. At the time of the report, DIZZINESS (dizzy/lightheaded), PRURITUS (itching /  Itching on lower legs / Itching on scalp) and RASH (rash on his chest, shoulders, both arms, on calf area and mid-back.) outcome was unknown.        mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.       The patient treated himself with lotions. It was not very effective. The patient feeling good as of now with no adverse effects.   This case was linked to MOD-2021-100762 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 28-Jun-2021: Significant follow up received: Medical history updated, concomitant medications updated, corrective treatment updated. Event terms and clinical course updated.
Age: 85.0
Sex: F
Vaccine: COVID19
Symptoms: Urinary tract infection
Clinical narrative: developed urinary tract infection; This spontaneous case was reported by a consumer and describes the occurrence of URINARY TRACT INFECTION (developed urinary tract infection) in an 85-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 016M20A) for COVID-19 vaccination.     The patient's past medical history included Chronic kidney infection. Concurrent medical conditions included UTI. Concomitant products included AMIODARONE, ESCITALOPRAM OXALATE (LEXAPRO), snythroid, RIVAROXABAN (XARELTO), CALCIUM CARBONATE, COLECALCIFEROL (VITAMIN D 2000), CYANOCOBALAMIN, PYRIDOXINE HYDROCHLORIDE, THIAMINE HYDROCHLORIDE (VITAMIN B 1-6-12), cranberry pill and TRANEXAMIC ACID (XANEXTRA) for an unknown indication.    On 05-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-Feb-2021, the patient experienced URINARY TRACT INFECTION (developed urinary tract infection). The patient was treated with CEFALEXIN (CEPHALEXINE) at an unspecified dose and frequency. At the time of the report, URINARY TRACT INFECTION (developed urinary tract infection) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Most recent FOLLOW-UP information incorporated above includes: On 30-Apr-2021: Additional clarification about UTI and medical history
Sex: F
Vaccine: COVID19
Symptoms: Rash
Clinical narrative: Facial Rash; This spontaneous case was reported by a consumer and describes the occurrence of RASH (Facial Rash) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013M20A) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced RASH (Facial Rash). At the time of the report, RASH (Facial Rash) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication details was reported. No treatment medication details was reported.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain upper, Nausea, Vomiting
Clinical narrative: Stomach pain; Nauseous; Vomiting; This spontaneous case was reported by a consumer and describes the occurrence of ABDOMINAL PAIN UPPER (Stomach pain), NAUSEA (Nauseous) and VOMITING (Vomiting) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013A21A) for COVID-19 immunisation.     No Medical History information was reported.    On 02-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Mar-2021, the patient experienced ABDOMINAL PAIN UPPER (Stomach pain), NAUSEA (Nauseous) and VOMITING (Vomiting). At the time of the report, ABDOMINAL PAIN UPPER (Stomach pain), NAUSEA (Nauseous) and VOMITING (Vomiting) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications provided.  No treatment information provided.
Age: 77.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain upper, Diarrhoea, Fatigue, Headache, Nausea
Clinical narrative: stomach cramps; stomach pain; Diarrhea after every meal and snack; lost weight; eight pounds; very fatigued; nausea without throw up; headaches; This spontaneous case was reported by a consumer and describes the occurrence of ABDOMINAL PAIN UPPER (stomach pain), DIARRHOEA (Diarrhea after every meal and snack), ABDOMINAL PAIN UPPER (stomach cramps), WEIGHT DECREASED (lost weight; eight pounds) and FATIGUE (very fatigued) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038K20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse reaction. Concomitant products included PANTOPRAZOLE for Acid reflux (oesophageal), LEVOTHYROXINE, METFORMIN and VITAMINS NOS for an unknown indication.    On 01-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 02-Feb-2021, the patient experienced DIARRHOEA (Diarrhea after every meal and snack), WEIGHT DECREASED (lost weight; eight pounds), FATIGUE (very fatigued), NAUSEA (nausea without throw up) and HEADACHE (headaches). On an unknown date, the patient experienced ABDOMINAL PAIN UPPER (stomach pain) and ABDOMINAL PAIN UPPER (stomach cramps). At the time of the report, ABDOMINAL PAIN UPPER (stomach pain), DIARRHOEA (Diarrhea after every meal and snack), ABDOMINAL PAIN UPPER (stomach cramps), WEIGHT DECREASED (lost weight; eight pounds), FATIGUE (very fatigued), NAUSEA (nausea without throw up) and HEADACHE (headaches) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Treatment details include ibuprofen and vitamins.
Age: 77.0
Sex: F
Vaccine: COVID19
Symptoms: Weight decreased
Clinical narrative: stomach cramps; stomach pain; Diarrhea after every meal and snack; lost weight; eight pounds; very fatigued; nausea without throw up; headaches; This spontaneous case was reported by a consumer and describes the occurrence of ABDOMINAL PAIN UPPER (stomach pain), DIARRHOEA (Diarrhea after every meal and snack), ABDOMINAL PAIN UPPER (stomach cramps), WEIGHT DECREASED (lost weight; eight pounds) and FATIGUE (very fatigued) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038K20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse reaction. Concomitant products included PANTOPRAZOLE for Acid reflux (oesophageal), LEVOTHYROXINE, METFORMIN and VITAMINS NOS for an unknown indication.    On 01-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 02-Feb-2021, the patient experienced DIARRHOEA (Diarrhea after every meal and snack), WEIGHT DECREASED (lost weight; eight pounds), FATIGUE (very fatigued), NAUSEA (nausea without throw up) and HEADACHE (headaches). On an unknown date, the patient experienced ABDOMINAL PAIN UPPER (stomach pain) and ABDOMINAL PAIN UPPER (stomach cramps). At the time of the report, ABDOMINAL PAIN UPPER (stomach pain), DIARRHOEA (Diarrhea after every meal and snack), ABDOMINAL PAIN UPPER (stomach cramps), WEIGHT DECREASED (lost weight; eight pounds), FATIGUE (very fatigued), NAUSEA (nausea without throw up) and HEADACHE (headaches) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Treatment details include ibuprofen and vitamins.
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Headache
Clinical narrative: Headache feels it mostly on one eye; A spontaneous report was received from a consumer (patient), concerning herself, a 72 years-old female patient, unknown race and ethnicity, who was administered Moderna's COVID-19 vaccine (mRNA-1273), and experienced headache feels it mostly on one eye (headache).  The patient's medical history was not provided. No relevant concomitant medications were reported.  On 02 Mar 2021, prior to the onset of the event, the patient received their second of two planned doses of mRNA-1273 (lot/batch: 023M20A), intramuscular for prophylaxis of COVID-19 infection.  On 03 Mar 2021, the patient experienced headache and feels it mostly on one eye. No treatment information was provided.  Action taken with second dose of mRNA-1273 in response to the event was not applicable.  The outcome of event, headache feels it mostly on one eye was not reported.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
Sex: M
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration
Clinical narrative: 2nd dose is scheduled for 24Feb2021 (33 days later); This spontaneous case was reported by a consumer and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (2nd dose is scheduled for 24Feb2021 (33 days later)) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (Medical history was not provided).    On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Jan-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (2nd dose is scheduled for 24Feb2021 (33 days later)). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (2nd dose is scheduled for 24Feb2021 (33 days later)) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       This report refers to a case of inappropriate schedule of vaccine administration for mRNA-1273, lot # unknown  with no associated AEs.   Reporter did not allow further contact; Sender's Comments: This report refers to a case of inappropriate schedule of vaccine administration for mRNA-1273, lot # unknown  with no associated AEs.
Sex: F
Vaccine: COVID19
Symptoms: Petechiae
Clinical narrative: petechiae on her back and abdomen; This spontaneous case was reported by a consumer and describes the occurrence of PETECHIAE (petechiae on her back and abdomen) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (medical history was not provided).    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PETECHIAE (petechiae on her back and abdomen). At the time of the report, PETECHIAE (petechiae on her back and abdomen) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported.  Treatment details was not reported.
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: Night sweats, Peripheral swelling, Pruritus
Clinical narrative: arm swollen and spreading; itchy; Night sweats; This spontaneous case was reported by a consumer and describes the occurrence of NIGHT SWEATS (Night sweats), PERIPHERAL SWELLING (arm swollen and spreading) and PRURITUS (itchy) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031L20A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included LEVOTHYROXINE SODIUM (SYNTHROID), ATENOLOL, ATORVASTATIN and PAROXETINE for an unknown indication.    On 18-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Feb-2021, the patient experienced NIGHT SWEATS (Night sweats). On 25-Feb-2021, the patient experienced PERIPHERAL SWELLING (arm swollen and spreading) and PRURITUS (itchy). The patient was treated with CORTISONE at an unspecified dose and frequency and BECLOMETASONE DIPROPIONATE (BECLOMETHASONE COX) at an unspecified dose and frequency. At the time of the report, NIGHT SWEATS (Night sweats), PERIPHERAL SWELLING (arm swollen and spreading) and PRURITUS (itchy) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Most recent FOLLOW-UP information incorporated above includes: On 01-May-2021: Updated events outcome as recovered/resolved.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Feeling hot, Injection site pruritus, Pain, Vaccination site erythema
Clinical narrative: sore; Shoulder pain; Warm; At injection itching; At injection inflamation; Red; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE PRURITUS (At injection itching), VACCINATION SITE REACTION (At injection inflamation), VACCINATION SITE ERYTHEMA (Red), FEELING HOT (Warm) and PAIN (sore) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 004M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 16-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Feb-2021, the patient experienced INJECTION SITE PRURITUS (At injection itching), VACCINATION SITE REACTION (At injection inflamation) and VACCINATION SITE ERYTHEMA (Red). On 03-Feb-2021, the patient experienced FEELING HOT (Warm). On 17-Feb-2021, the patient experienced PAIN (sore) and ARTHRALGIA (Shoulder pain). The patient was treated with HYDROGEN PEROXIDE (PEROXIDE) at an unspecified dose and frequency and PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, INJECTION SITE PRURITUS (At injection itching), VACCINATION SITE REACTION (At injection inflamation), VACCINATION SITE ERYTHEMA (Red), FEELING HOT (Warm), PAIN (sore) and ARTHRALGIA (Shoulder pain) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication details was reported.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site reaction
Clinical narrative: sore; Shoulder pain; Warm; At injection itching; At injection inflamation; Red; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE PRURITUS (At injection itching), VACCINATION SITE REACTION (At injection inflamation), VACCINATION SITE ERYTHEMA (Red), FEELING HOT (Warm) and PAIN (sore) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 004M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 16-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Feb-2021, the patient experienced INJECTION SITE PRURITUS (At injection itching), VACCINATION SITE REACTION (At injection inflamation) and VACCINATION SITE ERYTHEMA (Red). On 03-Feb-2021, the patient experienced FEELING HOT (Warm). On 17-Feb-2021, the patient experienced PAIN (sore) and ARTHRALGIA (Shoulder pain). The patient was treated with HYDROGEN PEROXIDE (PEROXIDE) at an unspecified dose and frequency and PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, INJECTION SITE PRURITUS (At injection itching), VACCINATION SITE REACTION (At injection inflamation), VACCINATION SITE ERYTHEMA (Red), FEELING HOT (Warm), PAIN (sore) and ARTHRALGIA (Shoulder pain) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication details was reported.
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Fatigue, Pruritus, Swelling
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of ERYTHEMA (redness), PRURITUS (itching), SWELLING (swelling) and FATIGUE (fatigue) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On an unknown date, the patient rceived first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ERYTHEMA (redness), PRURITUS (itching), SWELLING (swelling) and FATIGUE (fatigue). At the time of the report, ERYTHEMA (redness), PRURITUS (itching), SWELLING (swelling) and FATIGUE (fatigue) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. No concomitant medication details was reported. No treatment medication details was reported.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Cough, Dysgeusia, Fatigue, Parosmia
Clinical narrative: coughing; runny nose; coughing; chemical taste and smell after injection; chemical taste and smell after injection; chills; fatigue; rash around injection site; This spontaneous case was reported by a consumer and describes the occurrence of the first episode of COUGH (coughing), RHINORRHOEA (runny nose), the second episode of COUGH (coughing), DYSGEUSIA (chemical taste and smell after injection) and PAROSMIA (chemical taste and smell after injection) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 01-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced the first episode of COUGH (coughing), RHINORRHOEA (runny nose), the second episode of COUGH (coughing), DYSGEUSIA (chemical taste and smell after injection), PAROSMIA (chemical taste and smell after injection), CHILLS (chills), FATIGUE (fatigue) and VACCINATION SITE RASH (rash around injection site). At the time of the report, RHINORRHOEA (runny nose), the last episode of COUGH (coughing), DYSGEUSIA (chemical taste and smell after injection), PAROSMIA (chemical taste and smell after injection), CHILLS (chills), FATIGUE (fatigue) and VACCINATION SITE RASH (rash around injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication details was reported. No treatment medication details was reported.